Search results for "Enos"

showing 10 items of 1576 documents

The use of same in chemotherapy-induced liver injury

2018

Drug-induced liver injury (DILI) remains the most common cause of acute liver failure in the Western world. Chemotherapy is one of the major class of drugs most frequently associated with idiosyncratic DILI. For this reason, patients who receive chemotherapy require careful assessment of liver function prior to treatment to determine which drugs may not be appropriate and which drug doses should be modified. S-adenosylmethionine (SAMe) is an endogenous agent derived from methionine. Its supplementation is effective in the treatment of liver disease, in particular intrahepatic cholestasis (IHC). The target of this review is to analyze the mechanisms of hepatotoxicity of the principal antican…

medicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsDrug-induced liver injurySettore MED/06 - Oncologia Medicamedicine.medical_treatmentAntineoplastic AgentsGastroenterology03 medical and health sciencesLiver disease0302 clinical medicineCholestasisChemotherapy inducedInternal medicineNeoplasmsmedicineAnimalsHumansChemotherapyLiver injuryChemotherapyS-adenosylmethioninebusiness.industryHepatotoxicityHematologymedicine.diseaseOncologyCholestasi030220 oncology & carcinogenesisImmunohistochemistry030211 gastroenterology & hepatologyChemotherapy; Cholestasis; Drug-induced liver injury; Hepatotoxicity; S-adenosylmethionine; Hematology; OncologyLiver functionChemical and Drug Induced Liver InjuryComplicationbusiness
researchProduct

P1699Non-ST segment elevation miocardial infarction (NSTEMI) vs. Unstable angina (UA) in young women aged < 45 years - differences in symptomatolo…

2019

Abstract Background Almost 50% of all ACS in young women are NSTEMI and UA. Due to the type of ACS we observed differences in the symptomatology, treatment and outcomes. The aim was to evaluate the differences in the clinical course and prognosis in young women aged ≤45 years with NSTEMI vs. UA. Methods We compared 1143 women aged ≤45y.o. with acute cardiac syndromes: 51% NSTEMI, 49% UA from the PL-ACS registry between 2007 - 2014. Results Chest pain was predominant in both group, with a higher incidence in NSTEMI group (91.7% vs. 84.7, p=0.0002). UA group was older (42y.o. vs. 41y.o p=0.003), more often presents atypical symptoms (8.0% vs. 1.5%, p<0,0001) mostly with dyspnea (3.9%vs. 1.…

medicine.medical_specialtyEjection fractionUnstable anginabusiness.industryInfarctionClopidogrelmedicine.diseaseChest painRestenosisInternal medicineCardiologymedicineST segmentmedicine.symptomCardiology and Cardiovascular MedicinebusinessKillip classmedicine.drugEuropean Heart Journal
researchProduct

Endothelial nitric oxide synthase in vascular disease: from marvel to menace.

2006

Nitric oxide (NO·) is an important protective molecule in the vasculature, and endothelial NO· synthase (eNOS) is responsible for most of the vascular NO· produced. A functional eNOS oxidizes its substrate l -arginine to l -citrulline and NO·. This normal function of eNOS requires dimerization of the enzyme, the presence of the substrate l -arginine, and the essential cofactor (6 R )-5,6,7,8-tetrahydro- l -biopterin (BH 4 ), one of the most potent naturally occurring reducing agents. Cardiovascular risk factors such as hypertension, hypercholesterolemia, diabetes mellitus, or chronic smoking stimulate the production of reactive oxygen species in the vascular wall. Nicotinamide adenine dinu…

medicine.medical_specialtyEndotheliumNitric Oxide Synthase Type IIINitric OxideNitric oxidechemistry.chemical_compoundEnosPhysiology (medical)Internal medicinemedicineAnimalsHumansVascular Diseaseschemistry.chemical_classificationReactive oxygen speciesbiologySuperoxidebusiness.industrybiology.organism_classificationNitric oxide synthaseOxidative Stressmedicine.anatomical_structureEndocrinologychemistrybiology.proteinEndothelium VascularCardiology and Cardiovascular MedicinebusinessReactive Oxygen SpeciesNicotinamide adenine dinucleotide phosphatePeroxynitriteCirculation
researchProduct

Adenosine triphosphate bioluminescence in intensive care units: Be careful with its use

2016

LETTER TO EDITOR

medicine.medical_specialtyEpidemiologyIntensive Care UnitMEDLINEInfection controlPilot Projects030501 epidemiologylaw.invention03 medical and health scienceschemistry.chemical_compoundAdenosine Triphosphate0302 clinical medicinelawIntensive careInfection controlMedicineBioluminescence030212 general & internal medicineIntensive care medicinebusiness.industryHealth PolicyPublic Health Environmental and Occupational HealthIntensive care unitDisinfectionIntensive Care UnitsInfectious Diseaseschemistry0305 other medical sciencebusinessAdenosine triphosphateAmerican Journal of Infection Control
researchProduct

Radiologisch assistierte perkutane Gastro-/Enterostomie - Retrospektive Analyse von 90 Eingriffen

1996

PURPOSE To analyse retrospectively the indications, technique and results of radiologically induced gastrostomies or enterostomies. PATIENTS AND METHOD Radiologically assisted gastrostomies or enterostomies were induced in 90 patients, mostly with high grade obstructions due to head and neck tumours or oesophageal tumours. 19/90 patients had had previous resection of the oesophagus or gastric operations. RESULTS A catheter was successfully introduced in all patients. In 11/90 patients this was followed by a two-stage procedure. In 16/90 patients puncture was performed under CT control because of some anatomical peculiarity. Serious complication occurred in 9/90 patients but in only one was …

medicine.medical_specialtyEsophageal diseasebusiness.industrymedicine.medical_treatmentStomachmedicine.diseaseGastrostomySurgeryStenosisCathetermedicine.anatomical_structuremedicineRadiology Nuclear Medicine and imagingRadiologyEsophagusComplicationbusinessHead and neckRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
researchProduct

Inhibition of intracellular Ca2+ release by a Rho-kinase inhibitor for the treatment of ischemic damage in primary cultured rat hippocampal neurons.

2008

The effects of hydroxy fasudil, a specific Rho-kinase inhibitor, on behavior and brain neuronal activity in animal studies have been described previously. However, whether a Rho-kinase inhibitor can directly protect neurons against ischemic damage and the molecular mechanisms underlying these effects are poorly understood. The present work was designed to investigate the effect of hydroxy fasudil against oxygen-glucose deprivation (OGD) induced acute neuronal injury and the underlying mechanisms in vitro. Pretreatment with hydroxy fasudil at 5 and 10 microM could concentration-dependently improve cell viability and decrease Lactate dehydrogenase (LDH) level in extracellular solution of neur…

medicine.medical_specialtyExcitotoxicityIntracellular SpaceGlutamic AcidBiologymedicine.disease_causeNeuroprotectionHippocampusCalcium in biologyPotassium ChlorideRats Sprague-DawleyCalcium imagingAdenosine TriphosphateIschemiaInternal medicine1-(5-Isoquinolinesulfonyl)-2-MethylpiperazinemedicineAnimalsHypoxiaProtein Kinase InhibitorsCells CulturedPharmacologyNeuronsrho-Associated KinasesDose-Response Relationship DrugCalcium channelFasudilGlutamate receptorRatsEndocrinologyGlucoseRho kinase inhibitorCalciumEuropean journal of pharmacology
researchProduct

Sildenafil citrate improves perinatal outcome in fetuses from pre-eclamptic rats

2012

Please cite this paper as: Herraiz S, Pellicer B., Serra V, Cauli O, Cortijo J, Felipo V, Pellicer A. Sildenafil citrate improves perinatal outcome in fetuses from pre-eclamptic rats. BJOG 2012;119:1394–1402. Objective  To evaluate perinatal outcome after sildenafil citrate (SC) administration at the onset of pregnancy in a rat pre-eclampsia model. Design  In vivo animal experimental study. Setting  Fundacion IVI-Instituto Universitario IVI, Valencia, Spain. Sample Control and pre-eclampsia-induced pregnant Wistar rats exposed to chronic SC administration. Methods  We evaluated the use of SC, which was tested as a potential therapeutic tool to maintain vasodilatation in complicated pregnanc…

medicine.medical_specialtyFetusPregnancySildenafilbusiness.industryObstetricsObstetrics and GynecologyHemodynamicsmedicine.diseasechemistry.chemical_compoundBlood pressureEndocrinologychemistrymedicine.arteryInternal medicinemedicineUterine arterybusinessPerfusionDuctus venosusBJOG: An International Journal of Obstetrics & Gynaecology
researchProduct

OC005: Ultrasound bioeffects: Quantification of cellular damage in animal fetal liver after use of Doppler pulse to measure ductus venosus

2008

medicine.medical_specialtyFetusRadiological and Ultrasound TechnologyPulse (signal processing)business.industryUltrasoundMeasure (physics)Obstetrics and GynecologyGeneral Medicinesymbols.namesakeReproductive MedicineInternal medicinemedicinesymbolsCardiologyRadiology Nuclear Medicine and imagingbusinessDoppler effectDuctus venosusUltrasound in Obstetrics and Gynecology
researchProduct

OC133: Natriuretic peptide levels in IUGR fetuses with absent and reversed enddiastolic flow of the umbilical artery in relation to ductus venosus fl…

2003

medicine.medical_specialtyFetusRadiological and Ultrasound Technologybusiness.industrymedicine.drug_classObstetrics and GynecologyUmbilical arteryGeneral MedicineReproductive Medicinemedicine.arteryInternal medicinemedicineNatriuretic peptideCardiologyRadiology Nuclear Medicine and imagingbusinessDuctus venosusUltrasound in Obstetrics and Gynecology
researchProduct

Abnormalities of the umbilico-portal venous system in Down syndrome: A report of two new patients

2003

Congenital anomalies of the umbilical and portal venous system are rare vascular malformations which are often associated with anomalies of the heart and gastrointestinal tract. Association with chromosomal disorders has been sporadically reported. We now report on two patients with trisomy 21 and congenital anomalies of the umbilico-portal system. A male fetus showed absence of the intrahepatic portal vein (PV) and ductus venosus with a direct communication between portal sinus and inferior vena cava exhibiting an umbilicosystemic total shunt during the fetal life and a portosystemic total shunt after birth. A female infant showed absence of the intrahepatic PV and a total portocaval shunt…

medicine.medical_specialtyFetusbusiness.industryVascular malformationPortal venous systemAnatomymedicine.diseaseInferior vena cavaShunt (medical)medicine.veinInternal medicineGeneticsmedicineCardiologyPortosystemic shuntTrisomybusinessGenetics (clinical)Ductus venosusAmerican Journal of Medical Genetics Part A
researchProduct